Posted on 8/10/20
Verastem Oncology to Sell COPIKTRA (duvelisib) Rights to Secura Bio
BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced that it has . . .
Posted on 8/10/20
Gutenberg Technology Extends Partnership with CompTIA
BOSTON--(BUSINESS WIRE)--Gutenberg Technology (GT), provider of the premier end-to-end content management platform, today announced it has extended its partnership with the Computing Technology Industry Association (CompTIA), . . .
Posted on 8/10/20
David Mitchell Joins Liberty Bank as Chief Digital Officer, Digital Bank GM
David W. Glidden, President & CEO of Liberty Bank of Middletown, Connecticut, announced today that David
Posted on 8/10/20
MilliporeSigma’s Jeffrey Whitford Named to Fast Company’s ‘Most Creative People in Business’ List
Jeffrey Whitford has been named to Fast Company’s prestigious Most Creative People in Business list for 2020. Whitford heads MilliporeSigma’s sustainability, social business innovation and branding . . .
Posted on 8/10/20
Iron Mountain's Dividend Is Not Sustainable, But That Might Change
SummaryCurrent dividend levels are unsustainable; however, additional $350m in adjusted EBITDA in 2022 may change the picture.Company delivers 40%+ adjusted EBITDA margin in its two core . . .
Posted on 8/10/20
Iron Mountain To Raise $850M In A Private Placement
Iron Mountain (NYSE:IRM) launches private placement of $850M senior notes due 2031.Net proceeds wil be used to redeem all C$250M of the 53/8% senior notes due . . .
Posted on 8/10/20
Sean Murphy joins Radius Health Board of Directors
Radius Health, Inc. (Nasdaq: RDUS) today announced the appointment of Sean Murphy to its Board of Directors with immediate effect.
Posted on 8/10/20
Iron Mountain Incorporated Announces Debt Offering
BOSTON--(BUSINESS WIRE)--Iron Mountain Incorporated (NYSE: IRM), the storage and information management services company, today announced a proposed offering by way of a private placement of a . . .
Posted on 8/10/20
Sesen Bio Reports Second Quarter 2020 Financial Results and Business Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today reported operating results . . .
Posted on 8/10/20
Werewolf Therapeutics Appoints Ellen Lubman as Chief Business Officer
Werewolf Therapeutics, Inc., an oncology biotherapeutics company developing next-generation, transformative cancer therapeutics
Posted on 8/10/20
Paratek Pharmaceuticals Announces Second Quarter 2020 Total Revenue of $9.3M
BOSTON, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies . . .
Posted on 8/10/20
Siguler Guff Further Strengthens Credit Team
Siguler Guff, a multi-strategy private equity investment firm with over $14 billion of assets under management, announced today that the Firm has further strengthened its credit . . .
Posted on 8/10/20
WhiteHorse Capital Appoints Jason Hicks as Principal
NEW YORK--(BUSINESS WIRE)--WhiteHorse Capital, the direct lending affiliate of H.I.G. Capital, a leading global alternative investment firm with $39 billion of equity capital under management, is . . .
Posted on 8/10/20
Sage Therapeutics Announces Second Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Today, Sage Therapeutics, Inc. (NASDAQ:SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating . . .
Posted on 8/10/20
Momenta Pharmaceuticals Reports Second Quarter 2020 Financial and Operating Results
CAMBRIDGE, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat . . .
Posted on 8/10/20
Voyager Therapeutics Announces Second Quarter 2020 Financial Results and Corporate Updates
CAMBRIDGE, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR) today reported its second quarter 2020 financial results, program progress and corporate updates.“We . . .
Posted on 8/10/20
LogicBio Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Updates
LEXINGTON, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a company dedicated to extending the reach of genetic medicine with pioneering targeted delivery . . .
Posted on 8/10/20
Atea Pharmaceuticals Appoints Janet Hammond, M.D., Ph.D., as Chief Development Officer
BOSTON, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of next-generation therapeutics for severe human viral . . .
Posted on 8/10/20
Dyne Therapeutics Announces $115 Million Financing
Dyne Therapeutics, a biotechnology company focused on developing life-transforming therapies for patients with serious muscle diseases, today announced the closing of a $115 million equity financing
Posted on 8/10/20
2020’s Best & Worst States to Have a Baby – WalletHub Study
With the COVID-19 pandemic making birthing more stressful than usual and the average conventional delivery costing over $10,000, the personal-finance website WalletHub today released its report . . .
Posted on 8/10/20
Unemployment Fell in July -- but the Jobless Rate Is Still Dangerously High
COVID-19 sparked an unemployment crisis that the U.S. has been grappling with since March, and will most likely continue to struggle with through the end of . . .
Posted on 8/10/20
Bristol Myers' O+Y extends survival in rare type of thoracic cancer
Bristol Myers Squibb (NYSE:BMY) announces positive results from an open-label randomized Phase 3 clinical trial, CheckMate-743, comparing the combination of Opdivo (nivolumab) and Yervoy (ipilimumab) (O+Y) . . .
Posted on 8/10/20
Why Shares of General Electric Fell 11.1% in July
What happenedShares of General Electric (NYSE:GE) slid 11.1% in July, according to data from S&P Global Market Intelligence. It was yet another setback for the beaten-down . . .
Posted on 8/10/20
IPO Update: Duck Creek Technologies Proposes IPO Terms
SummaryDuck Creek Technologies has filed to raise $300 million in an IPO.The firm provides software and services to Property & Casualty insurance companies.DCT is growing revenue, . . .
Posted on 8/10/20
Why Vertex Pharmaceuticals Is the Best Biotech Stock to Buy in August
Cystic fibrosis (CF)is a life-threatening genetic disorder that causes mucus to accumulate in the lungs, digestive system, and other organs in the body, resulting in severe . . .

